Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Amyloidosis Channel is supported with funding from Prothena (Silver).

VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

Share this video  

ISA 2020 | Localized amyloidosis: symptoms and site of disease

Localized amyloidosis is typically immunoglobulin light chain associated (AL), although serum amyloid A protein and transthyretin have also been reported as causing localized disease. Localized amyloidosis often involves the laryngo-tracheobronchial tree, urogenital tract, and skin. Eli Muchtar, MD, Mayo Clinic, Rochester, MN, discusses localized amyloidosis compared to systemic amyloidosis, with localized amyloidosis diagnosis based on symptoms and site of localized disease. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).